Figure 1. Radiographic images of patient with a complete response.

Representative images were obtained (A) at baseline, (B) after completing induction with four treatments of ipilimumab every three weeks and (C) at 9 months (prior to the second dose of maintenance ipilimumab). The patient remains without evidence of recurrence 11.2 months after the start of protocol therapy.